title: Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate.
authors.affiliation: Department of Medicine Institute for Public Health and Medicine m-hinchcliff@northwestern.edu.
authors.forename: Monique E
authors.initials: ME
authors.lastname: Hinchcliff
authors.affiliation: Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
authors.forename: Jon
authors.initials: J
authors.lastname: Lomasney
authors.affiliation: Department of Medicine.
authors.forename: Julie A
authors.initials: JA
authors.lastname: Johnson
authors.affiliation: Department of Medicine.
authors.forename: John
authors.initials: J
authors.lastname: Varga
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001706:Biopsy; D019559:Capillary Leak Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate